India to Uganda: Artesunate Export Trade Route
India has recorded 116 verified shipments of Artesunate exported to Uganda, representing a combined trade value of $5.5M USD. This corridor is served by 21 active Indian exporters, with an average shipment value of $47.8K USD. The leading Indian exporter is SCOTT EDIL PHARMACIA LIMITED, which accounts for 31% of total export value with 29 shipments worth $1.7M USD. On the buying side, ROYAL PHARMA 2011 LIMITED is the largest importer in Uganda with $435.1K USD in purchases. The top 3 suppliers — SCOTT EDIL PHARMACIA LIMITED, SCOTT EDIL PHARMACIA LIMITED , SUPARSHVA RATNA SHRI INC — together control 62% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Uganda Artesunate corridor is one of India's established pharmaceutical export routes, with 116 shipments documented worth a combined $5.5M USD. The route is dominated by SCOTT EDIL PHARMACIA LIMITED, which alone accounts for roughly 31% of all export value, reflecting the consolidated nature of India's artesunate manufacturing sector.
Across 21 active suppliers, the average shipment value stands at $47.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 71% of all shipments, consistent with artesunate's non-urgent bulk-order profile.
Shipment activity peaks during October–December, with an average transit time of 18 days port-to-port. The route has recorded an annual growth rate of 29.7%, placing it at rank #14 among India's top artesunate export destinations globally.
On the import side, key buyers of Indian artesunate in Uganda include ROYAL PHARMA 2011 LIMITED , Novomed Healthcare Limited, TO THE ORDER and 37 others. ROYAL PHARMA 2011 LIMITED is the single largest importer with 3 shipments valued at $435.1K USD.
Route Characteristics
- Average transit
